BioSpace News Archive

Comp Resource Group has been recognized and awarded the 2019 Best of Delray Beach Award as the top Recruiting Agency by the Delray Beach Awards Program.

Nordic Nanovector ASA announces that following a safety review of the first patients in the ongoing Archer-1 trial investigating Betalutin® in combination with rituximab in second-line follicular lymphoma, the Betalutin® dose has been escalated to 15 MBq/kg for the next cohort of patients.

Investment will fund the commercial introduction of Cala Trio and expansion of the therapeutic platform

iX Biopharma Ltd announced that following the completion of its Phase 2 clinical study on Wafermine, a sublingual racemic ketamine wafer for the treatment of acute moderate to severe pain, the U.S. Food and Drug Administration has scheduled the End-of-Phase 2 meeting with the Company in the third quarter of 2019.

PolyPid Ltd. announced that the United States Food and Drug Administration (FDA) has granted a second Qualified Infectious Disease Product (QIDP) designation to D-PLEX100 for the prevention of post-abdominal surgery incisional infection.

With a Performance by Multi-Platinum Pop Artist Andy Grammer and a Prelude Performance by The Ransom Notes at the Annual AcceptAbility Gala in DC

A new study, released prior to one of the busiest travel weekends of the year, finds that over half of drivers would be encouraged to sanitize their car more often if it was more convenient

Lannett Company, Inc. announced that it completed the purchase of approximately $30.5 million, face value, of its Term A Loans in a private transaction.

Dr. Eckstein recently joined Apollo Ventures as Managing Partner.

Final analysis of SLU01 data confirmed promising clinical efficacy of DCVAC/LuCa active cellular immunotherapy product in patients with stage IV non-small cell lung cancer.